<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteInflammatory Diseases &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/application-area/inflammatory-diseases/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>Ropirio: Novel Treatments Targeting the Lymphatic System</title>
				<link>https://wyss.stage.a17.io/technology/ropirio-novel-treatments-targeting-the-lymphatic-system/</link>
        <pubDate>Wed, 11 Sep 2024 13:56:37 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Sangeeta Bhatia]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=40951</guid>
                            <description><a href="https://www.ropirio.com/">Ropirio Therapeutics</a> is developing the world’s first drug that directly targets and reactivates lymph vessels, and a platform for discovering more.</description>
                                        <content:encoded><![CDATA[<p>The human lymphatic system is vast and critical to our health, including the proper functioning of our immune system. Over the last decade, research into the lymph system has revealed its dysfunction in a wide variety of diseases, but development of drugs to directly target the lymph system has lagged, in part because there are few reliable preclinical models of lymph vessels on which to test drug&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/ropirio-novel-treatments-targeting-the-lymphatic-system/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/ropirio-novel-treatments-targeting-the-lymphatic-system/</link>
          <title>The human body's lymphatic system is a critical network that allows proper functioning of the immune system and movement of fluids, but it can become impaired due to inflammation. Ropirio is developing novel medicines that directly target the lymph vessels to treat a number of diseases. Credit: Envato Elements</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/09/09161236/doctor-checking-size-of-lymph-nodes-2023-11-27-05-27-54-utc.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=92d9a9e9aef3c38e0d004eb18b52f388"/></url>
				</image>
        			</item>

		
			<item>
				<title>Ropirio launches from Wyss Institute to develop first-in-class lymphatic medicines</title>
				<link>https://wyss.stage.a17.io/news/ropirio-launches-from-wyss-institute-to-develop-first-in-class-lymphatic-medicines/</link>
        <pubDate>Wed, 11 Sep 2024 13:55:12 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Sangeeta Bhatia]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40940</guid>
                            <description>The company is leveraging a discovery program developed at Harvard and Boston University to treat a wide range of serious diseases </description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; The Wyss Institute at Harvard University announced today that Ropirio Therapeutics, Inc. (Ropirio) has secured a worldwide, exclusive license from Harvard&rsquo;s Office of Technology Development (OTD) and Boston University (BU)&rsquo;s Technology Development office for novel molecules that activate the lymphatic system &ndash; a first in the pharma industry. &ldquo;There has been a&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/ropirio-launches-from-wyss-institute-to-develop-first-in-class-lymphatic-medicines/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/ropirio-launches-from-wyss-institute-to-develop-first-in-class-lymphatic-medicines/</link>
          <title>The human body's lymphatic system is a critical network that allows proper functioning of the immune system and movement of fluids, but it can become impaired due to inflammation. Ropirio is developing novel medicines that directly target the lymph vessels to treat a number of diseases. Credit: Envato Elements</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/09/09161236/doctor-checking-size-of-lymph-nodes-2023-11-27-05-27-54-utc.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=92d9a9e9aef3c38e0d004eb18b52f388"/></url>
				</image>
        			</item>

		
			<item>
				<title>Vinny Chandran Suja on Making Backpacks More Reliable and Predictable</title>
				<link>https://wyss.stage.a17.io/news/humans-of-the-wyss-vinny-chandran-suja-on-making-backpacks-more-reliable-and-predictable/</link>
        <pubDate>Tue, 20 Aug 2024 13:10:41 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Brain Disease]]></category>
		<category><![CDATA[Brain Health]]></category>
		<category><![CDATA[Brain Injury]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Nanoparticles]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40839</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. As a kid, Vinny Chandran Suja had no interest in biology. Instead, his math and science acumen led him to pursue degrees in mechanical and chemical engineering, studying non&#x2d;living systems.</p>
<p><a href="https://wyss.stage.a17.io/news/humans-of-the-wyss-vinny-chandran-suja-on-making-backpacks-more-reliable-and-predictable/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/humans-of-the-wyss-vinny-chandran-suja-on-making-backpacks-more-reliable-and-predictable/</link>
          <title>Vinny Chandran Suja, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University </title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/08/19095508/HoW-Vinny-Suja-04607.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=bdf61545789ef6d11eb055eb87b90950"/></url>
				</image>
        			</item>

		
			<item>
				<title>Engineered Live Biotherapeutic Product (eLBP) to Protect the Microbiome from Antibiotics</title>
				<link>https://wyss.stage.a17.io/technology/engineered-live-biotherapeutic-product-elbp-to-protect-the-microbiome-from-antibiotics/</link>
        <pubDate>Wed, 01 May 2024 14:44:43 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Antibiotic Resistance]]></category>
		<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[Pathogen]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=32666</guid>
                                                <content:encoded><![CDATA[<p>Antibiotics not only kill the pathogenic bacteria causing an infection, they also indiscriminately wreak havoc on the trillions of &ldquo;good&rdquo; bacteria making up the human microbiome. Known as &ldquo;dysbiosis,&rdquo; this alteration of our gut microbial composition manifests as discomforting diarrhea in up to 35% of patients in the short term, and can take months to resolve, often requiring dietary corrections&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/engineered-live-biotherapeutic-product-elbp-to-protect-the-microbiome-from-antibiotics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/engineered-live-biotherapeutic-product-elbp-to-protect-the-microbiome-from-antibiotics/</link>
          <title>Adobe Stock / Design Cells</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/04/08113739/AdobeStock_384900840.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=cde2ed85aed37e5d2812ff36986732f4"/></url>
				</image>
        			</item>

		
			<item>
				<title>Cellular “Backpacks” to Fight Cancer, Autoimmune Disorders, and More</title>
				<link>https://wyss.stage.a17.io/technology/cellular-backpacks-to-slow-tumor-growth/</link>
        <pubDate>Tue, 30 Apr 2024 20:33:51 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[Autoimmune Diseases]]></category>
		<category><![CDATA[Biomedicine]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Nanoparticles]]></category>
		<category><![CDATA[Samir Mitragotri]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=26339</guid>
                                                <content:encoded><![CDATA[<p>Macrophages are the body&rsquo;s multipurpose defense agents, patrolling for pathogens and engulfing cellular debris, foreign substances, microbes, and even cancer cells. But cancerous tumors have evolved an insidious defense mechanism: they can switch arriving macrophages from an active, pro&#x2d;inflammatory state to a passive, anti&#x2d;inflammatory state, in which they actually promote the tumor&rsquo;s growth.</p>
<p><a href="https://wyss.stage.a17.io/technology/cellular-backpacks-to-slow-tumor-growth/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/cellular-backpacks-to-slow-tumor-growth/</link>
          <title>The backpacks' disk shape (purple) allows them to attach to macrophages (white) without being engulfed and digested, helping to prolong the effects of their cargo. Credit: Wyss Institute at Harvard University.</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2020/04/27105523/Macrophage-Backpack-002-e1602597908410.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=a3e54fea4682c1e64a4b9b7a2f918271"/></url>
				</image>
        			</item>

		
			<item>
				<title>eRapid: Multiplexed Electrochemical Sensors for Fast, Accurate, Portable Diagnostics</title>
				<link>https://wyss.stage.a17.io/technology/erapid-multiplexed-electrochemical-sensors-for-fast-accurate-portable-diagnostics/</link>
        <pubDate>Tue, 30 Apr 2024 19:58:09 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[Anti-fouling]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biosensors]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Extracorporeal Devices]]></category>
		<category><![CDATA[Video]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=22660</guid>
                                                <content:encoded><![CDATA[<p>Handheld electrochemical sensors have revolutionized at&#x2d;home medical testing for diabetics, but they have not yet been successfully applied to diagnosing other conditions. These sensors are based on the activity of an enzyme, and there are only a limited number of enzymes that can be used to detect biomarkers of human disease. An alternative, much more broadly applicable sensing strategy based on&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/erapid-multiplexed-electrochemical-sensors-for-fast-accurate-portable-diagnostics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/erapid-multiplexed-electrochemical-sensors-for-fast-accurate-portable-diagnostics/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2019/11/08172632/eRapid-chip-photo-282A6480-Edit.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=2b582808a77dee8b5a41acc767f96de2"/></url>
				</image>
        			</item>

		
			<item>
				<title>Shining a light on the hidden damage of mild brain injuries</title>
				<link>https://wyss.stage.a17.io/news/shining-a-light-on-the-hidden-damage-of-mild-brain-injuries/</link>
        <pubDate>Wed, 03 Jan 2024 18:55:15 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedicine]]></category>
		<category><![CDATA[Boston Children's Hospital]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Brain Injury]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Samir Mitragotri]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=38668</guid>
                            <description>Immune cell-based imaging method enables diagnosis of mild traumatic brain injuries (mTBI) that do not show up on MRIs</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; Researchers have created a new brain imaging method that allows mild traumatic brain injuries (mTBIs) to be diagnosed, even when existing imaging techniques like magnetic resonance imaging (MRI) don&rsquo;t show any structural abnormalities. The technique involves loading gadolinium, a standard MRI contrast agent, into hydrogel&#x2d;based micropatches that are attached to&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/shining-a-light-on-the-hidden-damage-of-mild-brain-injuries/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/shining-a-light-on-the-hidden-damage-of-mild-brain-injuries/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/01/03093808/STM_Figure3A_left_insert.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=0cd779a4cf8752631f37a49502f03706"/></url>
				</image>
        			</item>

		
			<item>
				<title>A malaria drug treatment could save babies’ lives</title>
				<link>https://wyss.stage.a17.io/news/a-malaria-drug-treatment-could-save-babies-lives/</link>
        <pubDate>Tue, 19 Dec 2023 17:55:22 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gut-on-a-Chip]]></category>
		<category><![CDATA[Women's Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=38583</guid>
                            <description>Human organ chip research shows that a common antimalarial combination could reverse the negative effects of malnutrition in the female digestive tract that lead to low birth weight infants</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; Wars, drought, displacement, and instability are causing a dramatic increase in the number of pregnant and breastfeeding women around the world who suffer from malnutrition. Without access to sufficient nutrients in the womb, babies born to these women are more likely to die due to complications like pre&#x2d;term birth, low birth weight&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/a-malaria-drug-treatment-could-save-babies-lives/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/a-malaria-drug-treatment-could-save-babies-lives/</link>
          <title>This image shows the presence of villi (cyan) and the protein MUC2 (orange) that indicates mucus production on intestinal cells (nuclei are blue). Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/12/18110949/SMK_eBioMedicine_Small-Intestine_121823.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=cf82b8b2b3cf81c987a2f85efe5567d6"/></url>
				</image>
        			</item>

		
			<item>
				<title>Reimagining personalized medicine for each patient: Alican Ozkan</title>
				<link>https://wyss.stage.a17.io/news/reimagining-personalized-medicine-for-each-patient-alican-ozkan/</link>
        <pubDate>Thu, 07 Dec 2023 16:00:51 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Reimagine the World]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=38428</guid>
                            <description>After losing three grandparents to cancer and taking a close look at intestinal diseases, Postdoctoral Fellow Alican Ozkan is determined to find better therapeutic options for all patients, regardless of race, ethnicity, age, or sex</description>
                                        <content:encoded><![CDATA[<p>By Jessica Leff Listen to Alican tell his story. | Wyss Institute &middot; Alican Ozkan Reimagine The World On the banks of the Aegean Sea sits Izmir, the third&#x2d;most&#x2d;populous city in Turkey. It&rsquo;s geographically part of Asia, but culturally seems more at home in Europe. This is also the city where Alican Ozkan grew up. His parents, both chemical engineers, met at their university.</p>
<p><a href="https://wyss.stage.a17.io/news/reimagining-personalized-medicine-for-each-patient-alican-ozkan/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/reimagining-personalized-medicine-for-each-patient-alican-ozkan/</link>
          <title>Alican Ozkan is inspired to Reimagine the World with more personalized treatments for disease after watching his grandparents suffer with cancer and studying inflammatory bowel diseases. Credit: Wyss Institute at Harvard University </title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/12/07085733/Reimagine-the-World-Alican-Ozkan-00430-copy.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=386e35b24aaf4593fb24a4d510e11126"/></url>
				</image>
        			</item>

		
			<item>
				<title>Neha Kapate on Backpacking her way into a New Frontier for Treating Incurable Diseases</title>
				<link>https://wyss.stage.a17.io/news/humans-of-the-wyss-neha-kapate-on-backpacking-her-way-into-a-new-frontier-for-treating-incurable-diseases/</link>
        <pubDate>Fri, 23 Jun 2023 14:00:57 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Brain Injury]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Multiple Sclerosis (MS)]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=37091</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as scientists, and their collaborations at the Wyss Institute and beyond. Neha Kapate sees cell&#x2d;based therapies as a new frontier in disease treatment. Driven by a strong desire to help patients, she&rsquo;s using her chemical engineering background and a new cell therapy&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/humans-of-the-wyss-neha-kapate-on-backpacking-her-way-into-a-new-frontier-for-treating-incurable-diseases/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/humans-of-the-wyss-neha-kapate-on-backpacking-her-way-into-a-new-frontier-for-treating-incurable-diseases/</link>
          <title>Neha Kapate, Graduate Student Researcher. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/06/21094151/Neha-Kapate-HoW-3368.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=22c240965738b907a79ad4f74f0e7c5d"/></url>
				</image>
        			</item>

			</channel>
</rss>
